Literature DB >> 2217956

Rheumatoid arthritis.

T D Spector1.   

Abstract

RA is a common disease with a worldwide prevalence of about 1% with an annual incidence of about 3/10,000 adults. It is two to three times more common in women. There is some evidence that over the last few decades the disease is declining in incidence or severity. Patients with RA have a reduced life expectancy and a one in three chance of becoming disabled, depending on the severity of the disease at onset. The cause of the disease is unknown, although genetic factors account for up to 30% of disease susceptibility. The most important genetic factors are related to HLA-DR4 and DR1, which may have identical regions conferring the risk of disease. Many infectious agents have also been implicated in the etiology of RA, although there is no good epidemiologic evidence to support the laboratory findings. Hormonal and reproductive factors are known to play a major role in disease pathogenesis. Both pregnancy and the oral contraceptive pill are believed to be protective against development of the disease, although they may act by delaying or modifying the course of the disease rather than conferring "immunity".

Entities:  

Mesh:

Year:  1990        PMID: 2217956

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  46 in total

1.  Prevalence of immune disease in patients with wounds presenting to a tertiary wound healing centre.

Authors:  Victoria K Shanmugam; Amber Schilling; Anthony Germinario; Mihriye Mete; Paul Kim; John Steinberg; Christopher E Attinger
Journal:  Int Wound J       Date:  2011-12-14       Impact factor: 3.315

Review 2.  The melatonin-cytokine connection in rheumatoid arthritis.

Authors:  M Cutolo; G J M Maestroni
Journal:  Ann Rheum Dis       Date:  2005-08       Impact factor: 19.103

Review 3.  [Systemic manifestations of rheumatoid arthritis].

Authors:  M Uffmann
Journal:  Radiologe       Date:  2006-05       Impact factor: 0.635

Review 4.  Certolizumab pegol: a new biologic targeting rheumatoid arthritis.

Authors:  Aarat M Patel; Larry W Moreland
Journal:  Expert Rev Clin Immunol       Date:  2010-11       Impact factor: 4.473

5.  Is rheumatoid arthritis an infectious disease?

Authors:  A J Silman
Journal:  BMJ       Date:  1991-07-27

Review 6.  Cardiovascular comorbidity in rheumatic diseases: a focus on heart failure.

Authors:  Kerry Wright; Cynthia S Crowson; Sherine E Gabriel
Journal:  Heart Fail Clin       Date:  2014-01-10       Impact factor: 3.179

7.  Pulmonary tuberculosis and tuberculous arthritis of knee joint associated with rheumatoid arthritis treated with anti-tumor necrosis factor (TNF)-alpha medication: a case report.

Authors:  Selim Nalbant; Mustafa Özyurt; Murat Yıldırım; Mesih Kuskucu
Journal:  Rheumatol Int       Date:  2011-09-01       Impact factor: 2.631

Review 8.  Tapering biologics in rheumatoid arthritis: a pragmatic approach for clinical practice.

Authors:  Aleksander Lenert; Petar Lenert
Journal:  Clin Rheumatol       Date:  2016-11-28       Impact factor: 2.980

Review 9.  Interleukin-6 inhibition for treatment of rheumatoid arthritis: a review of tocilizumab therapy.

Authors:  Aarat M Patel; Larry W Moreland
Journal:  Drug Des Devel Ther       Date:  2010-10-01       Impact factor: 4.162

Review 10.  Do anti-TNF agents have equal efficacy in patients with rheumatoid arthritis?

Authors:  Sergio Schwartzman; Roy Fleischmann; G James Morgan
Journal:  Arthritis Res Ther       Date:  2004-06-21       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.